Statements of Condensed Consolidated Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Cash flows from operating activities:
Net earnings/(losses)	$ 5,880	$ (14,648)
Less: Net losses from discontinued operations, net of tax	(243)	(1,202)
Net earnings/(losses) from continuing operations	6,123	(13,446)
Adjustments to reconcile net earnings/(losses) to net cash provided by operating activities:
Depreciation and amortization	25,004	24,890
Impairment of goodwill	5,698	0
Gain on disposal of property, plant and equipment	(19,975)	(3,857)
Loss on extinguishment of debt	0	14,506
Earnings from unconsolidated companies, net of tax	(1,682)	(1,038)
Amortization of deferred financing costs and discount on secured term loan	1,443	2,439
Share-based compensation	3,733	2,991
Excess share-based compensation tax benefit	0	(96)
Change in provisions for uncertain tax positions	160	243
Change in deferred income tax	(1,912)	(8,039)
Other non-cash movements	17	752
Effect of exchange rates on net earnings/(losses)	2,358	(581)
Change in assets and liabilities, net of effects from acquisitions:
Accounts receivable	(5,971)	(5,077)
Due from unconsolidated companies	1,282	(520)
Prepaid expenses and other	(421)	1,131
Inventories	804	850
Escrow and prepaid customer deposits	(1,431)	(617)
Accounts payable	(309)	1,648
Accrued liabilities	12,582	3,383
Deferred revenue	11,630	10,050
Other, net	(2,475)	(5,438)
Other cash movements:
Dividends from equity method investees	1,879	1,620
Proceeds from insurance settlements	0	887
Payment of key money	0	(3,000)
Payment of swap termination costs	0	(3,985)
Net cash provided by operating activities from continuing operations	38,537	19,696
Net cash used in operating activities from discontinued operations	(243)	(1,202)
Net cash provided by operating activities	38,294	18,494
Cash flows from investing activities:
Capital expenditure to acquire property, plant and equipment	(31,365)	(40,040)
Capital expenditure to acquire intangible assets	(706)	0
Investments in unconsolidated companies	(4,061)	(4,844)
Increase in restricted cash	(153)	(613)
Release of restricted cash	500	6,900
Change in deferred revenue for asset sale deposits	(500)	0
Proceeds from insurance settlements	0	97
Proceeds from sale of property, plant and equipment and equity method investments	43,242	37,842
Net cash provided by/(used in) investing activities from continuing operations	6,957	(658)
Net cash provided by investing activities from discontinued operations	0	0
Net cash provided by/(used in) investing activities	6,957	(658)
Cash flows from financing activities:
Repayments of working capital loans	0	(137)
Payments for Repurchase of Equity	(16,519)	0
Exercised stock options and vested share awards	32	2
Excess share-based compensation tax benefit	0	96
Dividend to non-controlling interest	(20)	0
Issuance of long-term debt	0	569,097
Debt issuance costs	(1,000)	(16,254)
Principal payments under long-term debt	(2,740)	(561,934)
Net cash used in financing activities from continuing operations	(20,247)	(9,130)
Net cash used in financing activities from discontinued operations	0	0
Net cash used in financing activities	(20,247)	(9,130)
Effect of exchange rate changes on cash and cash equivalents	(3,433)	681
Net increase in cash and cash equivalents	21,571	9,387
Cash and cash equivalents at beginning of period (includes $Nil and $394 of cash presented within assets held for sale)	135,118	123,553
Cash and cash equivalents at end of period (includes $Nil and $Nil of cash presented within assets held for sale)	$ 156,689	$ 132,940